Dual modality of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical carcinoma of unknown primary

被引:53
作者
Freudenberg, LS
Fischer, M
Antoch, G
Jentzen, W
Gutzeit, A
Rosenbaum, SJ
Bockisch, A
Egelhof, T
机构
[1] Univ Hosp Essen, Clin Nucl Med, DE-45122 Essen, Germany
[2] Univ Hosp Essen, Dept Otorhinolaryngol, DE-45122 Essen, Germany
[3] Univ Hosp Essen, Dept Diagnost & Intervent Radiol, DE-45122 Essen, Germany
关键词
unknown primary tumor; positron emission tomography/computed tomography; fluorodeoxyglucose; dual modality;
D O I
10.1159/000084632
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate an optimized F-18-flurodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) acquisition protocol for head and neck cancer and assess the usefulness of combined FDGPET/CT in locating unknown primary tumors in patients with biopsy-proven cervical lymph node metastases. Subjects and Methods: Twenty-one patients with cervical lymph node metastases of unknown primary tumors underwent staging with FDG-PET/CT. The images of FDG-PET alone, CT alone, FDG-PET/CT read side by side and fused and FDG-PET/CT were evaluated separately by 2 physicians. Imaging results were correlated with either histology (n = 14) or clinical follow-up (n = 7). Results: On the fused FDG-PET/CT images, primary tumors were identified in 12 patients (57%); with FDG-PET alone and FDG-PET and CT read side by side 11 (52%) primary tumors were found while CT alone identified 5 (23%) primary tumors. Conclusion: Our data indicate that fused FDG-PET and CT images increased the sensitivity of detecting carcinoma of unknown primary (CUP) tumors compared to CT alone, but not to FDG-PET alone or FDG-PET and CT read side by side. Hence accurate fusion of functional and morphologic data by FDG-PET/CT is a promising imaging modality in the clinical workup of patients with cervical CUP tumors. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:155 / 160
页数:6
相关论文
共 43 条
[1]   UNKNOWN PRIMARY-CARCINOMA - NATURAL-HISTORY AND PROGNOSTIC FACTORS IN 657 CONSECUTIVE PATIENTS [J].
ABBRUZZESE, JL ;
ABBRUZZESE, MC ;
HESS, KR ;
RABER, MN ;
LENZI, R ;
FROST, P .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (06) :1272-1280
[2]  
Antoch G, 2004, J NUCL MED, V45, P357
[3]   Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: Introduction and evaluation [J].
Antoch, G ;
Kuehl, H ;
Kanja, J ;
Lauenstein, TC ;
Schneemann, H ;
Hauth, E ;
Jentzen, W ;
Beyer, T ;
Goehde, SC ;
Debatin, JF .
RADIOLOGY, 2004, 230 (03) :879-885
[4]   Non-small cell lung cancer: Dual-modality PET/CT in preoperative staging [J].
Antoch, G ;
Stattaus, J ;
Nemat, AT ;
Marnitz, S ;
Beyer, T ;
Kuehl, H ;
Bockisch, A ;
Debatin, JF ;
Freudenberg, LS .
RADIOLOGY, 2003, 229 (02) :526-533
[5]   Whole-body positron emission tomography-CT: Optimized CT using oral and IV contrast materials [J].
Antoch, G ;
Freudenberg, LS ;
Stattaus, J ;
Jentzen, W ;
Mueller, SP ;
Debatin, JF ;
Bockisch, A .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 179 (06) :1555-1560
[6]  
Antoch G, 2002, J NUCL MED, V43, P1339
[7]  
Beyer T, 2000, J NUCL MED, V41, P1369
[8]  
Beyer T, 2004, J NUCL MED, V45, p25S
[9]   Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology [J].
Beyer, T ;
Antoch, G ;
Blodgett, T ;
Freudenberg, LF ;
Akhurst, T ;
Mueller, S .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2003, 30 (04) :588-596
[10]  
Beyer T, 2002, Q J NUCL MED, V46, P24